Illumina (ILMN) Financials

$76.35 +1.82 (+2.44%)

Closing price 04:00 PM Eastern

Extended Trading

$75.79 -0.56 (-0.73%)

As of 04:37 PM Eastern

Annual Income Statements for Illumina

This table shows Illumina's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	1/3/2016	1/1/2017	12/31/2017	12/30/2018	12/29/2019	1/3/2021	1/2/2022	1/1/2023	12/31/2023	12/29/2024
Net Income / (Loss) Attributable to Common Shareholders	462	463	726	826	1,002	656	762	-4,404	-1,161	-1,223
Consolidated Net Income / (Loss)	458	428	678	782	990	656	762	-4,404	-1,161	-1,223
Net Income / (Loss) Continuing Operations	458	428	678	782	990	656	762	-4,404	-1,161	-1,223
Total Pre-Tax Income	583	561	1,043	894	1,118	856	884	-4,336	-1,117	-1,179
Total Operating Income	613	587	606	883	985	580	-123	-4,179	-1,069	-833
Total Gross Profit	1,549	1,666	1,826	2,300	2,467	2,203	3,154	2,972	2,744	2,861
Total Revenue	2,220	2,398	2,752	3,333	3,543	3,239	4,526	4,584	4,504	4,372
Operating Revenue	2,220	2,398	2,752	3,333	3,543	3,239	4,526	4,584	4,504	4,372
Total Cost of Revenue	671	732	926	1,033	1,076	1,036	1,372	1,612	1,760	1,511
Operating Cost of Revenue	671	732	926	1,033	1,076	1,036	1,372	1,612	1,760	1,511
Total Operating Expenses	936	1,079	1,220	1,417	1,482	1,623	3,277	7,151	3,813	3,694
Selling, General & Admin Expense	516	584	674	794	835	941	2,092	1,297	1,612	1,092
Research & Development Expense	401	504	546	623	647	682	1,185	1,321	1,354	1,169
Impairment Charge	-	-	-	-	-	0.00	0.00	3,914	827	1,889
Other Special Charges / (Income)	19	-9.00	-	-	-	0.00	0.00	619	20	-456
Total Other Income / (Expense), net	-30	-26	437	11	133	276	1,007	-157	-48	-346
Interest Expense	43	33	37	57	52	49	61	26	77	100
Interest & Investment Income	21	10	19	44	75	41	0.00	11	58	46
Other Income / (Expense), net	-8.00	-3.00	455	24	110	284	1,068	-142	-29	-292
Income Tax Expense	125	133	365	112	128	200	122	68	44	44
Basic Earnings per Share	$3.19	$3.09	$4.96	$5.63	$6.81	$4.48	$5.07	($28.00)	($7.34)	($7.69)
Weighted Average Basic Shares Outstanding	145M	147M	146M	147M	147M	147M	150M	157M	158M	159M
Diluted Earnings per Share	$3.10	$3.07	$4.92	$5.56	$6.74	$4.45	$5.04	($28.00)	($7.34)	($7.69)
Weighted Average Diluted Shares Outstanding	149M	148M	148M	149M	149M	148M	151M	157M	158M	159M
Weighted Average Basic & Diluted Shares Outstanding	144.70M	149.80M	146.40M	146.70M	147M	145.90M	157M	158M	158.90M	158.40M

This table shows Illumina's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	10/2/2022	1/1/2023	4/2/2023	7/2/2023	10/1/2023	12/31/2023	3/31/2024	6/30/2024	9/29/2024	12/29/2024
Net Income / (Loss) Attributable to Common Shareholders	-3,816	-139	3.00	-234	-754	-176	-126	-1,988	705	186
Consolidated Net Income / (Loss)	-3,816	-139	3.00	-234	-754	-176	-126	-1,988	705	186
Net Income / (Loss) Continuing Operations	-3,816	-139	3.00	-234	-754	-176	-126	-1,988	705	186
Total Pre-Tax Income	-3,672	-167	-78	-89	-782	-168	-109	-1,976	720	186
Total Operating Income	-3,657	-127	-64	-88	-754	-163	-111	-1,637	741	174
Total Gross Profit	717	673	655	732	684	673	667	721	745	728
Total Revenue	1,115	1,084	1,087	1,176	1,119	1,122	1,076	1,112	1,080	1,104
Operating Revenue	1,115	1,084	1,087	1,176	1,119	1,122	1,076	1,112	1,080	1,104
Total Cost of Revenue	398	411	432	444	435	449	409	391	335	376
Operating Cost of Revenue	398	411	432	444	435	449	409	391	335	376
Total Operating Expenses	4,374	800	719	820	1,438	836	778	2,358	4.00	554
Selling, General & Admin Expense	146	433	378	462	303	469	439	147	239	267
Research & Development Expense	325	346	341	358	315	340	339	325	253	252
Total Other Income / (Expense), net	-15	-40	-14	-1.00	-28	-5.00	2.00	-339	-21	12
Interest Expense	6.00	8.00	20	19	19	19	18	20	36	26
Interest & Investment Income	3.00	7.00	17	17	13	11	12	13	11	10
Other Income / (Expense), net	-12	-39	-11	1.00	-22	3.00	8.00	-332	4.00	28
Basic Earnings per Share	($24.26)	($0.89)	$0.02	($1.48)	($4.77)	($1.11)	($0.79)	($12.48)	$4.43	$1.17
Weighted Average Basic Shares Outstanding	157M	157M	158M	158M	158M	158M	159M	159M	159M	159M
Diluted Earnings per Share	($24.26)	($0.89)	$0.02	($1.48)	($4.77)	($1.11)	($0.79)	($12.48)	$4.42	$1.17
Weighted Average Diluted Shares Outstanding	157M	157M	158M	158M	158M	158M	159M	159M	160M	159M
Basic & Diluted Earnings per Share	-	($0.89)	-	-	-	($1.11)	-	-	-	$1.17
Weighted Average Basic & Diluted Shares Outstanding	157.30M	158M	158.10M	158.30M	158.80M	158.90M	159.30M	159.30M	158.60M	158.40M

This table details how cash moves in and out of Illumina's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	1/3/2016	1/1/2017	12/31/2017	12/30/2018	12/29/2019	1/3/2021	1/2/2022	1/1/2023	12/31/2023	12/29/2024
Net Change in Cash & Equivalents	133	-34	490	-77	898	-232	-578	779	-963	79
Net Cash From Operating Activities	786	779	875	1,142	1,051	1,080	545	392	478	837
Net Cash From Continuing Operating Activities	786	779	875	1,142	1,051	1,080	545	392	478	837
Net Income / (Loss) Continuing Operations	458	428	678	782	990	656	762	-4,404	-1,161	-1,223
Consolidated Net Income / (Loss)	458	428	678	782	990	656	762	-4,404	-1,161	-1,223
Depreciation Expense	73	90	110	140	151	156	176	215	235	224
Amortization Expense	93	81	76	80	83	71	107	179	197	130
Non-Cash Adjustments To Reconcile Net Income	121	131	-265	176	10	7.00	-276	4,426	1,354	2,616
Changes in Operating Assets and Liabilities, net	41	49	276	-36	-183	190	-224	-24	-147	-910
Net Cash From Investing Activities	-107	-515	-214	-1,813	745	-554	-1,069	-591	-231	-178
Net Cash From Continuing Investing Activities	-107	-515	-214	-1,813	745	-554	-1,069	-591	-231	-178
Purchase of Property, Plant & Equipment	-143	-260	-310	-296	-209	-189	-208	-286	-195	-128
Acquisitions	-37	-29	-2.00	-100	-29	-98	-2,444	-265	-30	-81
Purchase of Investments	-797	-895	-742	-2,859	-1,048	-2,058	221	-40	-6.00	-52
Divestitures	0.00	0.00	278	0.00	15	-	-	0.00	0.00	83
Net Cash From Financing Activities	-545	-296	-176	594	-897	-766	-51	1,000	-1,210	-570
Net Cash From Continuing Financing Activities	-545	-296	-176	594	-897	-766	-51	1,000	-1,210	-570
Repayment of Debt	-245	-66	-9.00	-4.00	-550	0.00	-517	0.00	-1,236	-750
Repurchase of Common Equity	-274	-249	-251	-201	-324	-736	-	0.00	0.00	-116
Payment of Dividends	-3.00	-29	-3.00	-	-	-	-	0.00	-1.00	-1.00
Issuance of Debt	0.00	5.00	5.00	735	0.00	0.00	988	991	0.00	1,241
Issuance of Common Equity	104	136	150	138	59	61	60	63	67	56
Other Financing Activities, net	-127	-93	-68	-74	-82	-91	-582	-54	-40	-1,000
Effect of Exchange Rate Changes	-1.00	-2.00	-	-	-1.00	8.00	-3.00	-22	0.00	-10
Cash Interest Paid	-	-	-	-	-	-	9.00	17	73	83
Cash Income Taxes Paid	17	60	149	99	164	119	233	122	65	105

This table details how cash moves in and out of Illumina's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	10/2/2022	1/1/2023	4/2/2023	7/2/2023	10/1/2023	12/31/2023	3/31/2024	6/30/2024	9/29/2024	12/29/2024
Net Change in Cash & Equivalents	-289	1,011	-517	59	-626	121	60	-188	-51	258
Net Cash From Operating Activities	-52	147	10	105	139	224	77	80	316	364
Net Cash From Continuing Operating Activities	-52	147	10	105	139	224	77	80	316	364
Net Income / (Loss) Continuing Operations	-3,816	-139	3.00	-234	-755	-175	-126	-1,988	704	187
Consolidated Net Income / (Loss)	-3,816	-139	3.00	-234	-755	-175	-126	-1,988	704	187
Depreciation Expense	56	57	57	59	59	60	59	57	54	54
Amortization Expense	47	49	50	49	49	49	49	48	16	17
Non-Cash Adjustments To Reconcile Net Income	4,008	152	108	128	973	145	129	2,308	113	66
Changes in Operating Assets and Liabilities, net	-347	28	-208	103	-187	145	-34	-345	-571	40
Net Cash From Investing Activities	-250	-102	-56	-37	-53	-85	-48	-41	-41	-48
Net Cash From Continuing Investing Activities	-250	-102	-56	-37	-53	-85	-48	-41	-41	-48
Purchase of Property, Plant & Equipment	-66	-88	-52	-47	-45	-51	-36	-31	-32	-29
Purchase of Investments	-4.00	-14	-3.00	-8.00	10	-5.00	-12	-10	-11	-19
Net Cash From Financing Activities	28	956	-473	-3.00	-707	-27	35	-226	-332	-47
Net Cash From Continuing Financing Activities	28	956	-473	-3.00	-707	-27	35	-226	-332	-47
Repurchase of Common Equity	-	-	-	-	-	-	-	-	-	-17
Other Financing Activities, net	-2.00	-35	-9.00	-3.00	-2.00	-26	-1.00	-969	-	-30
Effect of Exchange Rate Changes	-15	10	-	-	-5.00	9.00	-4.00	-1.00	6.00	-11

This table presents Illumina's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	1/3/2016	1/1/2017	12/31/2017	12/30/2018	12/29/2019	1/3/2021	1/2/2022	1/1/2023	12/31/2023	12/29/2024
Total Assets	3,688	4,281	5,257	6,959	7,316	7,585	15,217	12,252	10,111	6,303
Total Current Assets	2,097	2,318	2,980	4,490	4,451	4,483	2,713	3,561	2,609	2,746
Cash & Equivalents	769	735	1,225	1,144	2,042	1,810	1,232	2,011	1,048	1,127
Short-Term Investments	617	824	920	2,368	1,372	1,662	107	26	6.00	93
Accounts Receivable	386	381	411	514	573	487	648	671	734	735
Inventories, net	271	300	333	386	359	372	431	568	587	547
Prepaid Expenses	54	78	91	78	105	152	295	285	234	244
Plant, Property, & Equipment, net	343	713	931	1,075	889	922	1,024	1,091	1,007	815
Total Noncurrent Assets	1,248	1,250	1,346	1,394	1,976	2,180	11,480	7,600	6,495	2,742
Goodwill	753	776	771	831	824	897	7,113	3,239	2,545	1,113
Intangible Assets	274	243	175	185	145	142	3,250	3,285	2,993	295
Noncurrent Deferred & Refundable Income Taxes	135	123	88	70	64	-	-	-	56	567
Other Noncurrent Operating Assets	87	108	312	308	943	1,141	1,117	1,076	901	767
Total Liabilities & Shareholders' Equity	3,688	4,281	5,257	6,959	7,316	7,585	15,217	12,252	10,111	6,303
Total Liabilities	1,807	1,967	2,288	3,053	2,703	2,891	4,477	5,653	4,366	3,930
Total Current Liabilities	610	705	746	1,804	665	1,244	1,093	2,773	1,570	1,547
Short-Term Debt	75	2.00	10	1,107	0.00	511	0.00	1,248	0.00	499
Accounts Payable	139	138	160	184	149	192	332	293	245	221
Accrued Expenses	387	342	432	513	516	541	761	1,232	1,325	827
Total Noncurrent Liabilities	1,196	1,262	1,542	1,249	2,038	1,647	3,384	2,880	2,796	2,383
Long-Term Debt	1,016	1,056	1,182	890	1,141	673	1,695	1,487	1,489	1,490
Other Noncurrent Operating Liabilities	181	206	360	359	897	974	1,689	1,393	1,307	893
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,849	2,270	2,749	3,845	4,613	4,694	10,740	6,599	5,745	2,373
Total Preferred & Common Equity	1,849	2,197	2,749	3,758	4,613	4,694	10,740	6,599	5,745	2,373
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,849	2,197	2,749	3,758	4,613	4,694	10,740	6,599	5,745	2,373
Common Stock	2,499	2,735	2,835	3,292	3,562	3,817	8,940	9,209	9,557	7,527
Retained Earnings	1,023	1,485	2,256	3,083	4,067	4,723	5,485	1,142	-19	-1,242
Treasury Stock	-1,674	-2,022	-2,341	-2,616	-3,021	-3,848	-3,702	-3,755	-3,792	-3,934
Accumulated Other Comprehensive Income / (Loss)	0.04	-1.00	-1.00	-1.00	5.00	2.00	17	3.00	-1.00	22

This table presents Illumina's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	10/2/2022	1/1/2023	4/2/2023	7/2/2023	10/1/2023	12/31/2023	3/31/2024	6/30/2024	9/29/2024	12/29/2024
Total Assets	11,256	12,252	11,811	11,774	10,122	10,111	10,040	6,081	6,014	6,303
Total Current Assets	2,487	3,561	3,172	3,223	2,506	2,609	2,583	2,459	2,373	2,746
Cash & Equivalents	1,000	2,011	1,494	1,553	927	1,048	1,108	920	869	1,127
Short-Term Investments	41	26	24	6.00	6.00	6.00	-	74	70	93
Accounts Receivable	628	671	665	741	690	734	635	641	699	735
Inventories, net	559	568	586	617	615	587	584	561	574	547
Prepaid Expenses	259	285	403	306	268	234	256	263	161	244
Plant, Property, & Equipment, net	1,068	1,091	1,082	1,069	1,040	1,007	964	859	832	815
Total Noncurrent Assets	7,701	7,600	7,557	7,482	6,576	6,495	6,493	2,763	2,809	2,742
Goodwill	3,238	3,239	3,239	3,239	2,527	2,545	2,545	1,079	1,113	1,113
Intangible Assets	3,335	3,285	3,237	3,188	3,029	2,993	2,940	278	305	295
Noncurrent Deferred & Refundable Income Taxes	-	-	-	-	-	56	-	632	617	567
Other Noncurrent Operating Assets	1,128	1,076	1,081	1,055	1,020	901	1,008	774	774	767
Total Liabilities & Shareholders' Equity	11,256	12,252	11,811	11,774	10,122	10,111	10,040	6,081	6,014	6,303
Total Liabilities	4,525	5,653	5,118	5,219	4,224	4,366	4,306	4,645	3,889	3,930
Total Current Liabilities	2,669	2,773	2,230	2,303	1,482	1,570	1,474	2,208	975	1,547
Short-Term Debt	1,246	1,248	749	750	0.00	0.00	-	744	-	499
Accounts Payable	281	293	242	244	240	245	201	199	191	221
Accrued Expenses	1,142	1,232	1,239	1,309	1,242	1,325	1,273	1,265	784	827
Total Noncurrent Liabilities	1,856	2,880	2,888	2,916	2,742	2,796	2,832	2,437	2,914	2,383
Long-Term Debt	495	1,487	1,487	1,488	1,489	1,489	1,490	1,490	1,988	1,490
Other Noncurrent Operating Liabilities	1,361	1,393	1,401	1,428	1,253	1,307	1,342	947	926	893
Commitments & Contingencies	-	0.00	-	-	-	0.00	-	-	-	0.00
Total Equity & Noncontrolling Interests	6,731	6,599	6,693	6,555	5,898	5,745	5,734	1,436	2,125	2,373
Total Preferred & Common Equity	6,731	6,599	6,693	6,555	5,898	5,745	5,734	1,436	2,125	2,373
Preferred Stock	-	0.00	-	-	-	0.00	-	-	-	0.00
Total Common Equity	6,731	6,599	6,693	6,555	5,898	5,745	5,734	1,436	2,125	2,373
Common Stock	9,131	9,209	9,313	9,399	9,489	9,557	9,660	7,349	7,451	7,527
Retained Earnings	1,281	1,142	1,145	911	157	-19	-145	-2,133	-1,428	-1,242
Treasury Stock	-3,720	-3,755	-3,764	-3,767	-3,769	-3,792	-3,793	-	-3,893	-3,934
Accumulated Other Comprehensive Income / (Loss)	39	3.00	-1.00	12	21	-1.00	12	14	-5.00	22

This table displays calculated financial ratios and metrics derived from Illumina's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	1/3/2016	1/1/2017	12/31/2017	12/30/2018	12/29/2019	1/3/2021	1/2/2022	1/1/2023	12/31/2023	12/29/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	19.27%	8.02%	14.76%	21.11%	6.30%	-8.58%	39.73%	1.28%	-1.75%	-2.93%
EBITDA Growth	21.84%	-2.08%	65.17%	-9.62%	17.92%	-17.91%	12.56%	-419.79%	83.04%	-15.77%
EBIT Growth	25.48%	-3.47%	81.68%	-14.51%	20.73%	-21.10%	9.38%	-557.25%	74.59%	-2.46%
NOPAT Growth	18.82%	-7.00%	-12.04%	96.07%	12.93%	-49.04%	-123.85%	-2,659.07%	74.42%	22.08%
Net Income Growth	29.62%	-6.55%	58.41%	15.34%	26.60%	-33.74%	16.16%	-677.95%	73.64%	-5.34%
EPS Growth	30.80%	-0.97%	60.26%	13.01%	21.22%	-33.98%	13.26%	-677.95%	73.64%	-4.77%
Operating Cash Flow Growth	56.80%	-0.89%	12.32%	30.51%	-7.97%	2.76%	-49.54%	-28.07%	21.94%	75.10%
Free Cash Flow Firm Growth	-44.89%	15.28%	-13.33%	108.13%	132.33%	-59.00%	-2,424.00%	109.93%	-57.80%	565.83%
Invested Capital Growth	22.43%	14.35%	11.20%	18.60%	-2.13%	2.82%	361.18%	-34.24%	-15.31%	-49.16%
Revenue Q/Q Growth	3.71%	1.15%	6.13%	27.46%	-13.31%	0.03%	5.75%	-2.45%	0.85%	-0.41%
EBITDA Q/Q Growth	-6.86%	-0.20%	7.87%	0.45%	3.02%	3.90%	-11.78%	-6.97%	1.33%	29.59%
EBIT Q/Q Growth	-8.92%	-0.84%	9.38%	-1.52%	4.68%	4.22%	-17.32%	-6.59%	0.54%	24.34%
NOPAT Q/Q Growth	-9.62%	0.79%	-0.50%	19.20%	6.50%	-19.42%	-300.08%	-4.21%	-3.49%	28.80%
Net Income Q/Q Growth	-9.81%	0.83%	-6.74%	21.62%	4.43%	2.82%	-15.89%	-6.07%	-3.29%	22.84%
EPS Q/Q Growth	-9.62%	2.68%	-6.11%	20.61%	2.90%	3.49%	-15.44%	-6.07%	-3.29%	22.87%
Operating Cash Flow Q/Q Growth	40.42%	-11.86%	3.80%	0.53%	15.75%	-3.31%	-18.54%	-25.62%	19.20%	20.09%
Free Cash Flow Firm Q/Q Growth	7.80%	-3.32%	44.87%	5.14%	14.69%	-6.91%	-3.57%	12.45%	45.21%	-0.25%
Invested Capital Q/Q Growth	-3.29%	-2.31%	-4.91%	0.04%	-2.66%	-5.61%	0.74%	-1.80%	-4.25%	-1.01%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	69.77%	69.47%	66.35%	69.01%	69.63%	68.01%	69.69%	64.83%	60.92%	65.44%
EBITDA Margin	34.73%	31.48%	45.31%	33.81%	37.51%	33.68%	27.13%	-85.67%	-14.79%	-17.63%
Operating Margin	27.61%	24.48%	22.02%	26.49%	27.80%	17.91%	-2.72%	-91.16%	-23.73%	-19.05%
EBIT Margin	27.25%	24.35%	38.55%	27.21%	30.91%	26.67%	20.88%	-94.26%	-24.38%	-25.73%
Profit (Net Income) Margin	20.63%	17.85%	24.64%	23.46%	27.94%	20.25%	16.84%	-96.07%	-25.78%	-27.97%
Tax Burden Percent	78.56%	76.29%	65.00%	87.47%	88.55%	76.64%	86.20%	101.57%	103.94%	103.73%
Interest Burden Percent	96.36%	96.06%	98.30%	98.57%	102.10%	99.07%	93.55%	100.35%	101.73%	104.80%
Effective Tax Rate	21.44%	23.71%	35.00%	12.53%	11.45%	23.36%	13.80%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	33.44%	26.36%	20.58%	35.05%	36.87%	18.73%	-1.57%	-31.81%	-11.10%	-12.51%
ROIC Less NNEP Spread (ROIC-NNEP)	30.68%	31.34%	-18.50%	34.27%	30.65%	9.46%	-91.43%	-312.40%	-83.96%	-118.81%
Return on Net Nonoperating Assets (RNNOA)	44.79%	-5.95%	5.09%	-12.30%	-13.63%	-4.63%	11.44%	-18.99%	-7.71%	-17.62%
Return on Equity (ROE)	78.23%	20.40%	25.67%	22.75%	23.24%	14.10%	9.87%	-50.80%	-18.81%	-30.13%
Cash Return on Invested Capital (CROIC)	13.27%	12.96%	9.97%	18.03%	39.03%	15.95%	-130.29%	9.50%	5.47%	52.67%
Operating Return on Assets (OROA)	17.22%	14.66%	22.25%	14.85%	15.34%	11.60%	8.29%	-31.46%	-9.82%	-13.71%
Return on Assets (ROA)	13.03%	10.74%	14.22%	12.80%	13.87%	8.80%	6.68%	-32.07%	-10.38%	-14.90%
Return on Common Equity (ROCE)	76.05%	19.68%	24.03%	21.53%	22.84%	14.10%	9.87%	-50.80%	-18.81%	-30.13%
Return on Equity Simple (ROE_SIMPLE)	24.78%	19.48%	24.66%	20.81%	21.46%	13.98%	7.10%	-66.74%	-20.21%	-51.54%
Net Operating Profit after Tax (NOPAT)	482	448	394	772	872	444	-106	-2,925	-748	-583
NOPAT Margin	21.69%	18.68%	14.31%	23.17%	24.62%	13.72%	-2.34%	-63.82%	-16.61%	-13.34%
Net Nonoperating Expense Percent (NNEP)	2.76%	-4.98%	39.07%	0.78%	6.22%	9.27%	89.86%	280.59%	72.85%	106.30%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-31.34%	-10.34%	-13.37%
Cost of Revenue to Revenue	30.23%	30.53%	33.65%	30.99%	30.37%	31.99%	30.31%	35.17%	39.08%	34.56%
SG&A Expenses to Revenue	23.24%	24.35%	24.49%	23.82%	23.57%	29.05%	46.22%	28.29%	35.79%	24.98%
R&D to Revenue	18.06%	21.02%	19.84%	18.69%	18.26%	21.06%	26.18%	28.82%	30.06%	26.74%
Operating Expenses to Revenue	42.16%	45.00%	44.33%	42.51%	41.83%	50.11%	72.40%	156.00%	84.66%	84.49%
Earnings before Interest and Taxes (EBIT)	605	584	1,061	907	1,095	864	945	-4,321	-1,098	-1,125
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	771	755	1,247	1,127	1,329	1,091	1,228	-3,927	-666	-771
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	15.20	8.56	11.60	11.67	10.59	11.51	5.54	4.82	3.85	9.04
Price to Tangible Book Value (P/TBV)	34.17	15.97	17.69	15.99	13.40	14.78	157.73	424.08	106.82	22.23
Price to Revenue (P/Rev)	12.66	7.84	11.59	13.15	13.79	16.68	13.14	6.94	4.91	4.91
Price to Earnings (P/E)	60.82	40.62	43.94	53.07	48.75	82.35	78.04	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	1.64%	2.46%	2.28%	1.88%	2.05%	1.21%	1.28%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	17.56	10.16	15.46	17.76	19.90	21.50	5.39	4.45	3.65	7.07
Enterprise Value to Revenue (EV/Rev)	12.54	7.68	11.33	12.74	13.15	15.97	13.22	7.09	5.01	5.08
Enterprise Value to EBITDA (EV/EBITDA)	36.11	24.40	24.99	37.69	35.04	47.42	48.71	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	46.01	31.55	29.37	46.83	42.53	59.88	63.30	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	57.81	41.14	79.12	54.99	53.40	116.39	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	35.42	23.65	35.62	37.19	44.31	47.90	109.76	82.92	47.17	26.55
Enterprise Value to Free Cash Flow (EV/FCFF)	145.67	83.64	163.24	106.88	50.45	136.68	0.00	37.20	61.15	9.05
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.58	0.46	0.40	0.51	0.25	0.25	0.16	0.41	0.26	0.84
Long-Term Debt to Equity	0.54	0.46	0.40	0.23	0.25	0.14	0.16	0.23	0.26	0.63
Financial Leverage	1.46	-0.19	-0.28	-0.36	-0.44	-0.49	-0.13	0.06	0.09	0.15
Leverage Ratio	6.00	1.90	1.81	1.78	1.68	1.60	1.48	1.58	1.81	2.02
Compound Leverage Factor	5.78	1.82	1.77	1.75	1.71	1.59	1.38	1.59	1.84	2.12
Debt to Total Capital	36.70%	31.38%	28.65%	33.83%	19.83%	20.14%	13.63%	29.30%	20.58%	45.60%
Short-Term Debt to Total Capital	2.52%	0.06%	0.24%	18.75%	0.00%	8.69%	0.00%	13.37%	0.00%	11.44%
Long-Term Debt to Total Capital	34.18%	31.32%	28.41%	15.08%	19.83%	11.45%	13.63%	15.93%	20.58%	34.16%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	1.10%	3.47%	5.29%	2.51%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	62.21%	65.15%	66.07%	63.66%	80.17%	79.86%	86.37%	70.70%	79.42%	54.40%
Debt to EBITDA	1.41	1.40	0.96	1.77	0.86	1.09	1.38	-0.70	-2.24	-2.58
Net Debt to EBITDA	-0.38	-0.66	-0.76	-1.34	-1.71	-2.10	0.29	-0.18	-0.65	-1.00
Long-Term Debt to EBITDA	1.32	1.40	0.95	0.79	0.86	0.62	1.38	-0.38	-2.24	-1.93
Debt to NOPAT	2.26	2.36	3.03	2.59	1.31	2.66	-15.99	-0.93	-1.99	-3.41
Net Debt to NOPAT	-0.61	-1.12	-2.42	-1.96	-2.61	-5.15	-3.36	-0.24	-0.58	-1.32
Long-Term Debt to NOPAT	2.11	2.36	3.00	1.15	1.31	1.51	-15.99	-0.51	-1.99	-2.56
Altman Z-Score	11.35	7.69	10.67	10.61	13.22	13.40	9.10	2.79	3.25	3.33
Noncontrolling Interest Sharing Ratio	2.78%	3.56%	6.38%	5.35%	1.74%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.43	3.29	3.99	2.49	6.69	3.60	2.48	1.28	1.66	1.78
Quick Ratio	2.90	2.75	3.43	2.23	6.00	3.18	1.82	0.98	1.14	1.26
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	191	220	191	397	923	378	-8,796	874	369	2,455
Operating Cash Flow to CapEx	549.65%	299.62%	282.26%	385.81%	502.87%	571.43%	262.02%	137.06%	245.13%	653.91%
Free Cash Flow to Firm to Interest Expense	4.44	6.68	5.16	6.97	17.75	7.72	-144.20	33.60	4.79	24.55
Operating Cash Flow to Interest Expense	18.28	23.61	23.65	20.04	20.21	22.04	8.93	15.08	6.21	8.37
Operating Cash Flow Less CapEx to Interest Expense	14.95	15.73	15.27	14.84	16.19	18.18	5.52	4.08	3.68	7.09
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.63	0.60	0.58	0.55	0.50	0.43	0.40	0.33	0.40	0.53
Accounts Receivable Turnover	6.58	6.26	6.95	7.21	6.52	6.11	7.98	6.95	6.41	5.95
Inventory Turnover	2.91	2.56	2.93	2.87	2.89	2.83	3.42	3.23	3.05	2.66
Fixed Asset Turnover	7.30	4.54	3.35	3.32	3.61	3.58	4.65	4.33	4.29	4.80
Accounts Payable Turnover	6.05	5.28	6.21	6.01	6.46	6.08	5.24	5.16	6.54	6.49
Days Sales Outstanding (DSO)	55.49	58.34	52.52	50.65	55.99	59.73	45.77	52.51	56.93	61.32
Days Inventory Outstanding (DIO)	125.63	142.30	124.75	127.03	126.36	128.77	106.81	113.10	119.77	136.97
Days Payable Outstanding (DPO)	60.34	69.12	58.73	60.77	56.48	60.07	69.70	70.76	55.79	56.28
Cash Conversion Cycle (CCC)	120.78	131.52	118.55	116.90	125.87	128.43	82.88	94.85	120.91	142.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,585	1,813	2,016	2,391	2,340	2,406	11,096	7,297	6,180	3,142
Invested Capital Turnover	1.54	1.41	1.44	1.51	1.50	1.36	0.67	0.50	0.67	0.94
Increase / (Decrease) in Invested Capital	290	228	203	375	-51	66	8,690	-3,799	-1,117	-3,038
Enterprise Value (EV)	27,838	18,425	31,167	42,473	46,574	51,732	59,819	32,504	22,546	22,223
Market Capitalization	28,101	18,809	31,900	43,840	48,847	54,020	59,463	31,806	22,111	21,454
Book Value per Share	$12.63	$14.96	$18.83	$25.56	$31.38	$32.15	$68.71	$41.95	$36.18	$14.96
Tangible Book Value per Share	$5.62	$8.02	$12.35	$18.65	$24.79	$25.03	$2.41	$0.48	$1.30	$6.08
Total Capital	2,972	3,372	4,161	5,903	5,754	5,878	12,435	9,334	7,234	4,362
Total Debt	1,091	1,058	1,192	1,997	1,141	1,184	1,695	2,735	1,489	1,989
Total Long-Term Debt	1,016	1,056	1,182	890	1,141	673	1,695	1,487	1,489	1,490
Net Debt	-296	-501	-953	-1,515	-2,273	-2,288	356	698	435	769
Capital Expenditures (CapEx)	143	260	310	296	209	189	208	286	195	128
Debt-free, Cash-free Net Working Capital (DFCFNWC)	175	56	99	281	372	278	281	-1.00	-15	478
Debt-free Net Working Capital (DFNWC)	1,561	1,615	2,244	3,793	3,786	3,750	1,620	2,036	1,039	1,698
Net Working Capital (NWC)	1,486	1,613	2,234	2,686	3,786	3,239	1,620	788	1,039	1,199
Net Nonoperating Expense (NNE)	24	20	-284	-9.62	-118	-212	-868	1,479	413	640
Net Nonoperating Obligations (NNO)	-296	-501	-953	-1,515	-2,273	-2,288	356	698	435	769
Total Depreciation and Amortization (D&A)	166	171	186	220	234	227	283	394	432	354
Debt-free, Cash-free Net Working Capital to Revenue	7.88%	2.34%	3.60%	8.43%	10.50%	8.58%	6.21%	-0.02%	-0.33%	10.93%
Debt-free Net Working Capital to Revenue	70.33%	67.35%	81.54%	113.80%	106.86%	115.78%	35.79%	44.42%	23.07%	38.84%
Net Working Capital to Revenue	66.95%	67.26%	81.18%	80.59%	106.86%	100.00%	35.79%	17.19%	23.07%	27.42%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$3.10	$3.00	$4.82	$5.47	$6.62	$4.35	$4.93	($27.21)	($7.13)	($7.69)
Adjusted Weighted Average Basic Shares Outstanding	149.02M	151.04M	150.23M	151.26M	151.26M	151.26M	154.35M	161.55M	162.58M	159M
Adjusted Diluted Earnings per Share	$3.01	$2.98	$4.78	$5.40	$6.55	$4.32	$4.90	($27.21)	($7.13)	($7.69)
Adjusted Weighted Average Diluted Shares Outstanding	153.39M	152.33M	152.29M	153.32M	153.32M	152.29M	155.38M	161.55M	162.58M	159M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$6.62	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	151.26M	150.54M	151.26M	151.26M	151.26M	150.13M	161.55M	162.58M	163.51M	158.40M
Normalized Net Operating Profit after Tax (NOPAT)	496	441	394	772	872	444	-106	248	-155	420
Normalized NOPAT Margin	22.36%	18.39%	14.31%	23.17%	24.62%	13.72%	-2.34%	5.41%	-3.45%	9.61%
Pre Tax Income Margin	26.26%	23.39%	37.90%	26.82%	31.56%	26.43%	19.53%	-94.59%	-24.80%	-26.97%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	14.07	17.70	28.68	15.91	21.06	17.63	15.49	-166.19	-14.26	-11.25
NOPAT to Interest Expense	11.20	13.57	10.65	13.55	16.77	9.07	-1.74	-112.51	-9.72	-5.83
EBIT Less CapEx to Interest Expense	10.74	9.82	20.30	10.72	17.04	13.78	12.08	-177.19	-16.79	-12.53
NOPAT Less CapEx to Interest Expense	7.87	5.69	2.27	8.36	12.75	5.21	-5.15	-123.51	-12.25	-7.11
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.66%	6.78%	0.44%	0.00%	0.00%	0.00%	0.00%	0.00%	-0.09%	-0.08%
Augmented Payout Ratio	60.48%	64.95%	37.46%	25.70%	32.73%	112.20%	0.00%	0.00%	-0.09%	-9.57%

This table displays calculated financial ratios and metrics derived from Illumina's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	10/2/2022	1/1/2023	4/2/2023	7/2/2023	10/1/2023	12/31/2023	3/31/2024	6/30/2024	9/29/2024	12/29/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.63%	-9.59%	-11.12%	1.20%	0.36%	3.51%	-1.01%	-5.44%	-3.49%	-1.60%
EBITDA Growth	-804.74%	-130.61%	-86.50%	103.90%	81.27%	15.00%	-84.38%	-8,976.19%	222.01%	635.29%
EBIT Growth	-945.39%	-264.36%	-151.37%	86.23%	78.85%	3.61%	-37.33%	-2,163.22%	196.01%	226.25%
NOPAT Growth	-522.32%	-264.84%	-139.64%	84.80%	79.38%	-28.35%	-73.44%	-1,760.23%	237.47%	252.50%
Net Income Growth	-1,303.79%	-223.01%	-96.51%	56.26%	80.24%	-26.62%	-4,300.00%	-749.57%	193.50%	205.68%
EPS Growth	-1,266.35%	-223.01%	-96.36%	56.26%	80.24%	-26.62%	-4,050.00%	-743.24%	192.66%	205.41%
Operating Cash Flow Growth	80.88%	-47.87%	-94.19%	-16.00%	367.31%	52.38%	670.00%	-23.81%	127.34%	62.50%
Free Cash Flow Firm Growth	111.54%	142.96%	143.49%	140.99%	-56.14%	-72.97%	-67.65%	-4.19%	791.71%	220.27%
Invested Capital Growth	-32.54%	-34.24%	-33.94%	-33.37%	-13.15%	-15.31%	-17.47%	-63.01%	-50.82%	-49.16%
Revenue Q/Q Growth	-4.04%	-2.78%	0.28%	8.19%	-4.85%	0.27%	-4.10%	3.35%	-2.88%	2.22%
EBITDA Q/Q Growth	-562.83%	98.32%	153.33%	-34.38%	-3,280.95%	92.37%	109.80%	-37,380.00%	143.72%	-66.50%
EBIT Q/Q Growth	-480.54%	95.48%	54.82%	-16.00%	-791.95%	79.38%	35.63%	-1,811.65%	137.84%	-72.89%
NOPAT Q/Q Growth	-531.61%	96.53%	49.61%	-37.50%	-756.82%	78.38%	31.90%	-1,374.77%	163.32%	-76.02%
Net Income Q/Q Growth	-613.27%	96.36%	102.16%	-7,900.00%	-222.22%	76.66%	28.41%	-1,477.78%	135.46%	-73.62%
EPS Q/Q Growth	-613.53%	96.36%	102.25%	-7,900.00%	-222.22%	76.66%	28.83%	-1,479.75%	135.42%	-73.53%
Operating Cash Flow Q/Q Growth	-141.60%	382.69%	-93.20%	950.00%	32.38%	61.15%	-65.63%	3.90%	295.00%	15.19%
Free Cash Flow Firm Q/Q Growth	111.79%	262.28%	1.43%	-5.36%	-87.39%	123.26%	21.38%	180.30%	17.39%	-19.81%
Invested Capital Q/Q Growth	-31.56%	-1.80%	1.56%	-2.39%	-10.78%	-4.25%	-1.04%	-56.25%	18.61%	-1.01%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	64.30%	62.08%	60.26%	62.24%	61.13%	59.98%	61.99%	64.84%	68.98%	65.94%
EBITDA Margin	-319.82%	-5.54%	2.94%	1.79%	-59.70%	-4.55%	0.46%	-167.63%	75.46%	24.73%
Operating Margin	-327.98%	-11.72%	-5.89%	-7.48%	-67.38%	-14.53%	-10.32%	-147.21%	68.61%	15.76%
EBIT Margin	-329.06%	-15.31%	-6.90%	-7.40%	-69.35%	-14.26%	-9.57%	-177.07%	68.98%	18.30%
Profit (Net Income) Margin	-342.24%	-12.82%	0.28%	-19.90%	-67.38%	-15.69%	-11.71%	-178.78%	65.28%	16.85%
Tax Burden Percent	103.92%	83.23%	-3.85%	262.92%	96.42%	104.76%	115.60%	100.61%	97.92%	100.00%
Interest Burden Percent	100.08%	100.60%	104.00%	102.30%	100.77%	105.00%	105.83%	100.36%	96.64%	92.08%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	2.08%	0.00%
Return on Invested Capital (ROIC)	-116.97%	-4.09%	-1.97%	-2.58%	-30.34%	-6.80%	-4.80%	-92.11%	61.26%	14.78%
ROIC Less NNEP Spread (ROIC-NNEP)	-340.88%	-13.59%	7.21%	-34.16%	-66.36%	-17.72%	-13.58%	-179.87%	58.70%	16.78%
Return on Net Nonoperating Assets (RNNOA)	-22.08%	-0.83%	0.43%	-2.19%	-6.60%	-1.63%	-1.20%	-43.20%	11.74%	2.49%
Return on Equity (ROE)	-139.05%	-4.91%	-1.54%	-4.78%	-36.94%	-8.42%	-6.00%	-135.31%	73.01%	17.27%
Cash Return on Invested Capital (CROIC)	8.42%	9.50%	7.61%	9.59%	3.66%	5.47%	7.60%	54.34%	51.12%	52.67%
Operating Return on Assets (OROA)	-117.50%	-5.11%	-2.27%	-2.43%	-28.97%	-5.74%	-3.94%	-87.84%	37.53%	9.75%
Return on Assets (ROA)	-122.21%	-4.28%	0.09%	-6.52%	-28.15%	-6.32%	-4.82%	-88.69%	35.52%	8.98%
Return on Common Equity (ROCE)	-139.05%	-4.91%	-1.54%	-4.78%	-36.94%	-8.42%	-6.00%	-135.31%	73.01%	17.27%
Return on Equity Simple (ROE_SIMPLE)	-61.68%	0.00%	-67.04%	-63.86%	-19.06%	0.00%	-22.50%	-211.98%	-74.59%	0.00%
Net Operating Profit after Tax (NOPAT)	-2,560	-89	-45	-62	-528	-114	-78	-1,146	726	174
NOPAT Margin	-229.59%	-8.20%	-4.12%	-5.24%	-47.17%	-10.17%	-7.22%	-103.05%	67.18%	15.76%
Net Nonoperating Expense Percent (NNEP)	223.90%	9.51%	-9.17%	31.58%	36.02%	10.93%	8.78%	87.76%	2.56%	-1.99%
Return On Investment Capital (ROIC_SIMPLE)	-	-0.95%	-	-	-	-1.58%	-	-	-	3.99%
Cost of Revenue to Revenue	35.70%	37.92%	39.74%	37.76%	38.87%	40.02%	38.01%	35.16%	31.02%	34.06%
SG&A Expenses to Revenue	13.09%	39.94%	34.77%	39.29%	27.08%	41.80%	40.80%	13.22%	22.13%	24.18%
R&D to Revenue	29.15%	31.92%	31.37%	30.44%	28.15%	30.30%	31.51%	29.23%	23.43%	22.83%
Operating Expenses to Revenue	392.29%	73.80%	66.15%	69.73%	128.51%	74.51%	72.30%	212.05%	0.37%	50.18%
Earnings before Interest and Taxes (EBIT)	-3,669	-166	-75	-87	-776	-160	-103	-1,969	745	202
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-3,566	-60	32	21	-668	-51	5.00	-1,864	815	273
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	4.46	4.82	5.49	4.52	3.68	3.85	3.80	11.91	9.75	9.04
Price to Tangible Book Value (P/TBV)	189.94	424.08	169.32	231.58	63.54	106.82	87.58	216.58	29.32	22.23
Price to Revenue (P/Rev)	6.39	6.94	8.26	6.64	4.87	4.91	4.85	3.86	4.72	4.91
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	4.13	4.45	5.05	4.19	3.45	3.65	3.63	6.86	6.86	7.07
Enterprise Value to Revenue (EV/Rev)	6.54	7.09	8.42	6.80	4.99	5.01	4.94	4.14	4.96	5.08
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	58.28	82.92	162.87	144.39	55.58	47.17	40.71	35.29	31.24	26.55
Enterprise Value to Free Cash Flow (EV/FCFF)	39.53	37.20	52.83	34.94	87.78	61.15	43.18	6.82	8.85	9.05
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.26	0.41	0.33	0.34	0.25	0.26	0.26	1.56	0.94	0.84
Long-Term Debt to Equity	0.07	0.23	0.22	0.23	0.25	0.26	0.26	1.04	0.94	0.63
Financial Leverage	0.06	0.06	0.06	0.06	0.10	0.09	0.09	0.24	0.20	0.15
Leverage Ratio	1.52	1.58	1.54	1.60	1.69	1.81	1.76	2.23	2.01	2.02
Compound Leverage Factor	1.52	1.59	1.60	1.64	1.71	1.90	1.86	2.24	1.94	1.86
Debt to Total Capital	20.55%	29.30%	25.04%	25.45%	20.16%	20.58%	20.63%	60.87%	48.33%	45.60%
Short-Term Debt to Total Capital	14.71%	13.37%	8.39%	8.53%	0.00%	0.00%	0.00%	20.27%	0.00%	11.44%
Long-Term Debt to Total Capital	5.84%	15.93%	16.65%	16.92%	20.16%	20.58%	20.63%	40.60%	48.33%	34.16%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	79.45%	70.70%	74.96%	74.55%	79.84%	79.42%	79.37%	39.13%	51.67%	54.40%
Debt to EBITDA	-0.47	-0.70	-0.54	-0.63	-2.21	-2.24	-2.15	-0.87	-1.82	-2.58
Net Debt to EBITDA	-0.19	-0.18	-0.17	-0.19	-0.82	-0.65	-0.55	-0.48	-0.96	-1.00
Long-Term Debt to EBITDA	-0.13	-0.38	-0.36	-0.42	-2.21	-2.24	-2.15	-0.58	-1.82	-1.93
Debt to NOPAT	-0.62	-0.93	-0.72	-0.81	-2.06	-1.99	-1.91	-1.20	-2.43	-3.41
Net Debt to NOPAT	-0.25	-0.24	-0.23	-0.25	-0.77	-0.58	-0.49	-0.66	-1.28	-1.32
Long-Term Debt to NOPAT	-0.18	-0.51	-0.48	-0.54	-2.06	-1.99	-1.91	-0.80	-2.43	-2.56
Altman Z-Score	3.46	3.91	4.89	3.96	3.42	3.55	3.56	1.43	4.28	4.03
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.93	1.28	1.42	1.40	1.69	1.66	1.75	1.11	2.43	1.78
Quick Ratio	0.63	0.98	0.98	1.00	1.10	1.14	1.18	0.74	1.68	1.26
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	1,024	3,710	3,763	3,561	449	1,003	1,217	3,412	4,006	3,212
Operating Cash Flow to CapEx	-78.79%	167.05%	19.23%	223.40%	308.89%	439.22%	213.89%	258.06%	987.50%	1,255.17%
Free Cash Flow to Firm to Interest Expense	170.68	463.76	188.16	187.44	23.64	52.78	67.63	170.61	111.27	123.54
Operating Cash Flow to Interest Expense	-8.67	18.38	0.50	5.53	7.32	11.79	4.28	4.00	8.78	14.00
Operating Cash Flow Less CapEx to Interest Expense	-19.67	7.38	-2.10	3.05	4.95	9.11	2.28	2.45	7.89	12.88
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.36	0.33	0.33	0.33	0.42	0.40	0.41	0.50	0.54	0.53
Accounts Receivable Turnover	7.63	6.95	6.96	6.45	6.78	6.41	6.91	6.41	6.32	5.95
Inventory Turnover	3.30	3.23	3.11	2.97	2.93	3.05	2.97	2.86	2.66	2.66
Fixed Asset Turnover	4.52	4.33	4.20	4.20	4.24	4.29	4.39	4.59	4.69	4.80
Accounts Payable Turnover	5.98	5.16	6.14	6.41	6.61	6.54	7.84	7.60	7.35	6.49
Days Sales Outstanding (DSO)	47.85	52.51	52.48	56.57	53.86	56.93	52.80	56.95	57.74	61.32
Days Inventory Outstanding (DIO)	110.75	113.10	117.24	122.93	124.42	119.77	122.93	127.66	136.99	136.97
Days Payable Outstanding (DPO)	61.03	70.76	59.46	56.97	55.22	55.79	46.54	48.01	49.66	56.28
Cash Conversion Cycle (CCC)	97.57	94.85	110.26	122.53	123.07	120.91	129.19	136.60	145.08	142.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	7,431	7,297	7,411	7,234	6,454	6,180	6,116	2,676	3,174	3,142
Invested Capital Turnover	0.51	0.50	0.48	0.49	0.64	0.67	0.66	0.89	0.91	0.94
Increase / (Decrease) in Invested Capital	-3,584	-3,799	-3,808	-3,623	-977	-1,117	-1,295	-4,558	-3,280	-3,038
Enterprise Value (EV)	30,711	32,504	37,461	30,321	22,287	22,546	22,188	18,350	21,777	22,223
Market Capitalization	30,011	31,806	36,743	29,642	21,731	22,111	21,806	17,110	20,728	21,454
Book Value per Share	$42.79	$41.95	$42.36	$41.46	$37.26	$36.18	$36.06	$9.01	$13.34	$14.96
Tangible Book Value per Share	$1.00	$0.48	$1.37	$0.81	$2.16	$1.30	$1.57	$0.50	$4.44	$6.08
Total Capital	8,472	9,334	8,929	8,793	7,387	7,234	7,224	3,670	4,113	4,362
Total Debt	1,741	2,735	2,236	2,238	1,489	1,489	1,490	2,234	1,988	1,989
Total Long-Term Debt	495	1,487	1,487	1,488	1,489	1,489	1,490	1,490	1,988	1,490
Net Debt	700	698	718	679	556	435	382	1,240	1,049	769
Capital Expenditures (CapEx)	66	88	52	47	45	51	36	31	32	29
Debt-free, Cash-free Net Working Capital (DFCFNWC)	23	-1.00	173	111	91	-15	1.00	1.00	459	478
Debt-free Net Working Capital (DFNWC)	1,064	2,036	1,691	1,670	1,024	1,039	1,109	995	1,398	1,698
Net Working Capital (NWC)	-182	788	942	920	1,024	1,039	1,109	251	1,398	1,199
Net Nonoperating Expense (NNE)	1,256	50	-48	172	226	62	48	842	21	-12
Net Nonoperating Obligations (NNO)	700	698	718	679	556	435	382	1,240	1,049	769
Total Depreciation and Amortization (D&A)	103	106	107	108	108	109	108	105	70	71
Debt-free, Cash-free Net Working Capital to Revenue	0.49%	-0.02%	3.89%	2.49%	2.04%	-0.33%	0.02%	0.02%	10.46%	10.93%
Debt-free Net Working Capital to Revenue	22.64%	44.42%	38.02%	37.43%	22.93%	23.07%	24.68%	22.47%	31.85%	38.84%
Net Working Capital to Revenue	-3.87%	17.19%	21.18%	20.62%	22.93%	23.07%	24.68%	5.67%	31.85%	27.42%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($23.58)	($0.86)	$0.02	($1.44)	($4.64)	($1.08)	($0.77)	($12.48)	$4.43	$1.17
Adjusted Weighted Average Basic Shares Outstanding	161.55M	161.55M	162.58M	162.58M	162.58M	162.58M	163.61M	159M	159M	159M
Adjusted Diluted Earnings per Share	($23.58)	($0.86)	$0.02	($1.44)	($4.64)	($1.08)	($0.77)	($12.48)	$4.42	$1.17
Adjusted Weighted Average Diluted Shares Outstanding	161.55M	161.55M	162.58M	162.58M	162.58M	162.58M	163.61M	159M	160M	159M
Adjusted Basic & Diluted Earnings per Share	$0.00	($0.86)	$0.00	$0.00	$0.00	($1.08)	$0.00	$0.00	$0.00	$1.17
Adjusted Weighted Average Basic & Diluted Shares Outstanding	161.86M	162.58M	162.68M	162.89M	163.40M	163.51M	163.92M	159.30M	158.60M	158.40M
Normalized Net Operating Profit after Tax (NOPAT)	172	-89	-45	-62	46	-114	-78	174	248	122
Normalized NOPAT Margin	15.44%	-8.20%	-4.12%	-5.24%	4.13%	-10.17%	-7.22%	15.67%	22.94%	11.03%
Pre Tax Income Margin	-329.33%	-15.41%	-7.18%	-7.57%	-69.88%	-14.97%	-10.13%	-177.70%	66.67%	16.85%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-611.50	-20.75	-3.75	-4.58	-40.84	-8.42	-5.72	-98.45	20.69	7.77
NOPAT to Interest Expense	-426.65	-11.11	-2.24	-3.24	-27.78	-6.01	-4.32	-57.30	20.15	6.69
EBIT Less CapEx to Interest Expense	-622.50	-31.75	-6.35	-7.05	-43.21	-11.11	-7.72	-100.00	19.81	6.65
NOPAT Less CapEx to Interest Expense	-437.65	-22.11	-4.84	-5.72	-30.15	-8.69	-6.32	-58.85	19.27	5.58
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	-0.09%	0.00%	0.00%	0.00%	-0.08%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	-0.09%	0.00%	0.00%	0.00%	-9.57%

Frequently Asked Questions About Illumina's Financials

When does Illumina's fiscal year end?

According to the most recent income statement we have on file, Illumina's financial year ends in December. Their financial year 2024 ended on December 29, 2024.

How has Illumina's net income changed over the last 9 years?

Illumina's net income appears to be on an upward trend, with a most recent value of -$1.22 billion in 2024, falling from $458 million in 2015. The previous period was -$1.16 billion in 2023. See where experts think Illumina is headed by visiting Illumina's forecast page.

What is Illumina's operating income?

Illumina's total operating income in 2024 was -$833 million, based on the following breakdown:

Total Gross Profit: $2.86 billion
Total Operating Expenses: $3.69 billion

How has Illumina revenue changed over the last 9 years?

Over the last 9 years, Illumina's total revenue changed from $2.22 billion in 2015 to $4.37 billion in 2024, a change of 96.9%.

How much debt does Illumina have?

Illumina's total liabilities were at $3.93 billion at the end of 2024, a 10.0% decrease from 2023, and a 117.5% increase since 2015.

How much cash does Illumina have?

In the past 9 years, Illumina's cash and equivalents has ranged from $735 million in 2016 to $2.04 billion in 2019, and is currently $1.13 billion as of their latest financial filing in 2024.

How has Illumina's book value per share changed over the last 9 years?

Over the last 9 years, Illumina's book value per share changed from 12.63 in 2015 to 14.96 in 2024, a change of 18.5%.

Related Companies

This page (NASDAQ:ILMN) was last updated on 5/7/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Illumina (ILMN) Financials

Frequently Asked Questions About Illumina's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Illumina (ILMN) Financials

Annual Income Statements for Illumina

Quarterly Income Statements for Illumina

Annual Cash Flow Statements for Illumina

Quarterly Cash Flow Statements for Illumina

Annual Balance Sheets for Illumina

Quarterly Balance Sheets for Illumina

Annual Metrics and Ratios for Illumina

Quarterly Metrics and Ratios for Illumina

Frequently Asked Questions About Illumina's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools